The DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index; none of the 234 sources its claims cite is checked for support yet.
Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations
Open accessAbstract
The production of neurotoxic amyloid-β peptides (Aβ) is central to the initiation and progression of Alzheimer's disease (AD) and involves sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. APP and the secretases are transmembrane proteins and their co-localisation in the same membrane-bound sub-compartment is necessary for APP cleavage. The intracellular trafficking of APP and the β-secretase, BACE1, is critical in regulating APP processing and Aβ production and has been studied in several cellular systems. Here, we summarise the intracellular distribution and transport of APP and its secretases, and the intracellular location for APP cleavage in non-polarised cells and neuronal models. In addition, we review recent advances on the potential impact of familial AD mutations on APP trafficking and processing. This is critical information in understanding the molecular mechanisms of AD progression and in supporting the development of novel strategies for clinical treatment.
Overview
CoChat Summary
TL;DR
This review summarizes the cell biology of APP trafficking and processing, emphasizing that APP and BACE1 are largely segregated and that amyloidogenic cleavage can occur in multiple compartments, especially the Golgi/TGN and endosomes. It highlights that familial AD mutations, notably APP Swedish, can shift the major processing site to the secretory pathway/Golgi and are linked to organelle abnormalities.
Key findings
- APP and BACE1 follow distinct post-Golgi itineraries in non-polarised cells: APP is transported from the TGN to early endosomes via AP4/Arl5b with low plasma membrane levels, while BACE1 goes directly to the plasma membrane and recycles; the TGN/Golgi and early endosomes are prime convergence sites.
- In primary neurons, APP and BACE1 show only low co-localisation under physiological conditions; synaptic activity can increase their convergence and β-cleavage products (C99) and Aβ secretion.
- The familial APP Swedish mutation (K595/M596→N595/L596 in APP695) is adjacent to the β-cleavage site; purified BACE1 cleaves APPswe faster than APPwt, with synthetic peptide cleavage 10-fold higher and kcat/Km 60-fold higher; APPswe is predominantly cleaved in the secretory pathway/Golgi, whereas APPwt is preferentially cleaved in the endocytic pathway.
- Familial AD mutations are numerous (114 APP mutations; >360 PSEN1 and >90 PSEN2 pathogenic mutations), many near the transmembrane domain/cleavage sites; PSEN mutations can alter APP trafficking and cause organelle abnormalities, including Golgi fragmentation and enlarged endosomes in iPSC-derived neurons.
Methods
- Narrative review synthesizing published literature on intracellular distribution/trafficking of APP and secretases, sites of APP processing in non-polarised cells and neuronal models, and effects of familial AD mutations.
- Evidence base includes immortalised cell lines, primary rodent neurons, rodent brain sections, human iPSC-derived neurons, and patient/post-mortem tissues; Tables 1–3 summarize localisation, cleavage products, and unanswered questions.
- Main analysis is qualitative synthesis with figures/tables; no new experimental data, systematic search, or meta-analysis.
Limitations
- Stated in paper: challenges include comparing different cell lines, overexpression effects, sorting motif/adaptor pleiotropy, antibody specificity, older microscopy resolution limits, steady-state Aβ localisation, multiple mutants in the same line, and multiple processing compartments.
- Stated in paper: many unanswered questions remain (Table 3), including when/where APP and BACE1 converge in neurons, whether disease mutations alter processing location in primary neurons, and the role of cholesterol-rich microdomains.
- Evident from text: as a narrative review, it does not systematically appraise study quality or quantify effects; conclusions rely on cited studies, many from non-neuronal or overexpression systems, with limited human neuronal data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. Trafficking itineraries of APP and the β-secretase BACE1 in non-polarised cells. Intracellular trafficking itineraries of APP and the β-secretase BACE1 in non-polarised cells are illustrated in blue and red, respectively. Both APP and BACE1 are synthesised in the endoplasmic reticulum (ER) and transported to the Golgi apparatus. APP and BACE1 segregate within the Golgi stack and are sorted into different transport carriers at the trans-Golgi network (TGN). The bulk of APP is transported to the early endosomes and then transported along the late endosome-lysosome pathway in cultured cells using protocols to synchronise trafficking of APP from the ER [47,48]. Low levels of APP are transported to the cell surface as quantified by TIRF [48] and are present at steady state as assessed by subcellular fractionation [49]. In contrast, BACE1 is sorted directly to the plasma membrane [50]. BACE1 can be actively internalised and recycled through the recycling endosomes, while APP showed minimal localisation to the recycling endosomes. Hence, the TGN and the early endosomes serve as potential sites for the β-cleavage of APP.](https://figures.cochat.ai/paper-figures/6f375d5ded924c009e2c7aa5a54b48a8/advances-in-the-cell-biology-of-the-trafficking-and-processing-of-amyloid-figure-2.jpg)



Verification
Claims the paper makes
0 Valid · 1 Not valid · 158 Not checked · 55 Own results and interpretations
A statement the paper makes itself — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As APP and the secretases are all membrane-bound proteins, the co-localisation of APP and its secretases is required for cleavage events to occur”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Trafficking and sorting of APP in non-neuronal cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The specificity of the antibodies used to detect intracellular APP needs to be rigorously defined as they often have the potential to recognise several APP fragments.”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > AD and the amyloid cascade model > Main challenges to define the intracellular locations of APP processing
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
In the paper
“somatic APP resides predominantly in the Golgi and early or late endosomes in neurons”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Intracellular distribution of APP in the polarised domains of rodent neurons
What the sources say
- Not checked yetcites [71] 2012, Amyloid precursor protein revisited neuron-specific expression and highly stable nature of soluble derivatives, J. Biol. Chem. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“APP cargo has been observed to traffic back to the TGN from the early endosomes through the retromer-mediated retrograde transport”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Trafficking and sorting of APP in non-neuronal cells
What the sources say
- Not checked yetcites [59] 2012, Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network, Proc. Natl Acad. Sci. U.S.A. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the tyrosine-based YTSI motif in the cytoplasmic tail can interact with the adaptor protein AP-3, to mediate APP traffic to the lysosomes for degradation”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Trafficking and sorting of APP in non-neuronal cells
What the sources say
- Not checked yetcites [67] 2016, Tyrosine binding protein sites regulate the intracellular trafficking and processing of amyloid precursor protein through a novel lysosome-directed pathway, PLoS One source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
160 more claims
Create a free account to see all 214 claims and to verify the 233 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 10
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277
Signals for Sorting of Transmembrane Proteins to Endosomes and Lysosomes
Bonifacino, J. S., & Traub, L. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161800 · Cited by 2,040
Research works printed but not linked: 1
- 2000, Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis, Ann. Neurol., 47, 249, 10.1002/1531-8249(200002)47:2<249::aid-ana18>3.0.co;2-8 · doi:10.1002/1531-8249(200002)47:2<249::aid-ana18>3.0.co;2-8
Cited by
Revisiting the role of Annexins in membrane trafficking
Grewal, T., Gerke, V., Nylandsted, J., Rentero, C., & Enrich, C. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05780-z · Cited by 20
Gioé-Gallo, C., Ortigueira, S., Prieto‐Díaz, R., Contino, M., Azuaje, J., Perrone, M. G., Riganti, C., Alberga, D., Mangiatordi, G. F., Andújar-Arias, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00604 · Cited by 8
Alameen, A. A. M., Al‐kuraishy, H. M., Al-Gareeb, A. I., Shokr, M. M., & Batiha, G. E. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104947 · Cited by 7
Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6
Self-citationImpact of Golgi dynamics and Golgi morphology on the regulation of glycosylation
Gleeson, P. A. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130919 · Cited by 3
Self-citation
Metadata
- Authors
- Wang, J., Fourriere, L., & Gleeson, P. A.
- Affiliations
- The University of Melbourne (AU)
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
- Corresponding author
- Gleeson, Paul A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2024-09-20
- Volume
- 481
- Issue
- 19
- Pages
- 1297-1325
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC11555708
- OpenAlex
- W4402681980
- Cited by
- 27
- References
- 273
- Citations by year
- 2026: 19 · 2025: 8
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochemical Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Medical Research Council
- National Health and Medical Research Council (2013384)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid precursor protein, amyloid-beta, Alzheimer's disease, familial Alzheimer's disease mutations, BACE1, beta-secretase, gamma-secretase, APP processing, intracellular trafficking, APP cleavage, neuron models
- MeSH terms
- Alzheimer Disease, Animals, Humans, Mutation, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Protein Transport, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations. https://app.cochat.ai/papers/10.1042/bcj20240056
- The paper
- Wang, J., Fourriere, L., & Gleeson, P. A. (2024). Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations. Biochemical Journal. https://doi.org/10.1042/bcj20240056
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.